The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sheremet N.L.

FGBU "NII glaznykh bolezneĭ" RAMN

Mikaelyan A.A.

Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021

Andreev A.Yu.

Sverdlovsk Regional Clinical Hospital №1, Ekaterinberg

Kiselev S.L.

Privolzhskiy Research Medical University, Nizhniy Novgorod, Russia

Possibilities of treating retinal diseases in patients with damaged retinal pigment epithelium

Authors:

Sheremet N.L., Mikaelyan A.A., Andreev A.Yu., Kiselev S.L.

More about the authors

Journal: Russian Annals of Ophthalmology. 2019;135(5‑2): 226‑234

DOI: 10.17116/oftalma2019135052226

Read: 237 times

Download PDF (RU)
Contact the author
Table of contents

POSSIBILITIES OF TREATING RETINAL DISEASES IN PATIENTS WITH DAMAGED RETINAL PIGMENT EPITHELIUM
POSSIBILITIES OF TREATING RETINAL DISEASES IN PATIENTS WITH DAMAGED RETINAL PIGMENT EPITHELIUM

To cite this article:

Sheremet NL, Mikaelyan AA, Andreev AYu, Kiselev SL. Possibilities of treating retinal diseases in patients with damaged retinal pigment epithelium. Russian Annals of Ophthalmology. 2019;135(5‑2):226‑234. (In Russ.)
https://doi.org/10.17116/oftalma2019135052226

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Neuronal models based on olfa­ctory epithelial cells in the study of the pathogenesis of mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):20-25
Motor beha­vior in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mice model of Parkinson’s disease treated with reco­mbinant spidroin rS1/9 microgel. Mole­cular Gene­tics, Microbiology and Viro­logy. 2024;(4):12-17
Auto­logous adipose-derived stem cells for the treatment of complex cryptoglandular fistula (systematic review and meta-analysis). Plastic Surgery and Aesthetic Medi­cine. 2025;(2):117-127
Towa­rds highly precise treatment and reha­bilitation in practice of modern cardiologist, cardiac surgeon and cardiac reha­bilitation professional. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):343-350
The type 1 diabetes mellitus treatment. Russian Journal of Preventive Medi­cine. 2025;(8):131-137
Abstract:

Retinal diseases associated with damage to retinal pigment epithelium (PPE) are the most frequent causes of irreversible loss of vision in adults. Since there is no therapeutic treatment available that could repair RPE and its connections with the adjacent photoreceptors, the review focuses on various methods of surgical treatment. One of the most promising methods at present is the use of stem cells derivatives. Results of numerous experimental and clinical trials show that use of human induced pluripotent stem cells in the treatment of degenerative diseases of the retina can be considered effective and promising.

Keywords:

retinal degeneration
retinal dystrophy
retinal pigment epithelium
stem cells
induced pluripotent stem cells

Authors:

Sheremet N.L.

FGBU "NII glaznykh bolezneĭ" RAMN

Mikaelyan A.A.

Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021

Andreev A.Yu.

Sverdlovsk Regional Clinical Hospital №1, Ekaterinberg

Kiselev S.L.

Privolzhskiy Research Medical University, Nizhniy Novgorod, Russia

Close metadata

References:

  1. Sheremet NL, Ronzina IA, Zhorzholadze NV, Strel’nikov VV. Relationship between structural and functional changes in retina in Stargardt disease. Vestnik oftal’mologii. 2016;132(3):42-48. (In Russ.) https://doi.org/10.17116/oftalma2016132342-48
  2. Al-Nawaiseh S, Thieltges F, Liu Z, Strack C, Brinken R, Braun N, Wolschendorf M, Maminishkis A, Eter N, Stanzel BV. A step by step protocol for subretinal surgery in rabbits. Journal of Visualized Experiments. 2016;115:e53927. https://doi.org/10.3791/53927
  3. Strauss O. The retinal pigment epithelium in visual function. Physiological Reviews. 2005;85(3):845-881.
  4. Machalińska A, Lubiński W, Kłos P, Kawa M, Baumert B, Penkala K, Grzegrzółka R, Karczewicz D, Wiszniewska B, Machaliński B. Sodium iodate selectively injuries the posterior pole of the retina in a dose-dependent manner: morphological and electrophysiological study. Neurochemical Research. 2010;35(11):1819-1827. https://doi.org/10.1007/s11064-010-0248-6
  5. Egorova TE. Antioxidants in treatment and prophylaxis of dry type of age — related macular degeneration. Literary review. Klinicheskaya oftal’mologiya. 2010;11(2):69-71. (In Russ.)
  6. Sheremet NL, Zhorzholadze NV, Ronzina IA, Grushke IG, Kurbatov SA, Chukhrova AL, Loginova AN, Shcherbakova PO, Tanas AS, Polyakov AV, Strel’nikov VV. Molecular-genetic diagnosis of Stargardt’s disease. Vestnik oftal’mologii. 2017;133(4):4-11. (In Russ.) https://doi.org/10.17116/oftalma201713344-11
  7. RetNet: https://sph.uth.edu/Retnet/sum-dis.htm
  8. Ostrovskii MA. Molekulyarnye mekhanizmy povrezhdayushchego deistviya sveta na struktury glaza. Klinicheskaya fiziologiya zreniya. 3-e izd. Pod red. Shamshinovoi AM. M.: MBN; 2006. (In Russ.)
  9. Klien BA, Krill AE. Fundus flavimaculatus. Clinical, functional and histopathologic observations. American Journal of Ophthalmology. 1967;64(1):3-23. https://doi.org/10.1016/0002-9394(67)93339-9
  10. Bondarenko MT, Zhorzholadze NV, Sheremet NL, Ronzina IA, Galoian NS, Loginova AN, Chukhrova AL, Poliakov AV. Stargardt’s disease and abiotrophy of Franceschetti (fundus flavimaculatus): pathogenetic, clinical, and molecular genetic characteristics. Vestnik oftal’mologii. 2014;130(2):72-76. (In Russ.)
  11. Rapp LM, Maple SS, Choi JH. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Investigative Ophthalmology & Visual Science. 2000;41:1200-1209.
  12. Teleuova TS, Mambetova MM, Toktabekova GE, Usmanova AG. Results of application of a preparation of Okuvayt Lutein complex treatment of patients age makulyarny degenerations. Vestnik AGIUV. 2012;1(17):51-52. (In Russ.)
  13. Trieschmann M, Beatty S, Nolan JM, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res. 2007;84(4):718-728. https://doi.org/10.1016/j.exer.2006.12.010
  14. Delcourt C, Carrière I, Delage M, Barberger-Gateau P, Schalch W; POLA Study Group. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factor for age—related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci. 2006;47:2329-2335. https://doi.org/10.1167/iovs.05-1235
  15. Chew EY, Clemons TE, SanGiovanni JP, Danis R, Ferris III FL, Elman M, Antoszyk A, Ruby A, Orth D, Bressler S, Fish G, Hubbard B, Klein M, Chandra S, Blodi B, Domalpally A, Friberg T, Wong W, Rosenfeld P, Agron E, Toth C, Bernstein P, Sperduto R. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005-2015. https://doi.org/10.1001/jama.2013.4997
  16. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol. 1993;231(11):635-641.
  17. da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P. RPE transplantation and its role in retinal disease. Prog Retin Eye Res. 2007;26(6):598-635. https://doi.org/10.1016/j.preteyeres.2007.07.001
  18. Chen FK, Patel PJ, Uppal GS, Tufail A, Coffey PJ, da Cruz L. Long-term outcomes following full macular translocation surgery in neovascular age-related macular degeneration. The British Journal of Ophthalmology. 2010;94(10):1337-1343. https://doi.org/10.1136/bjo.2009.172593
  19. MacLaren RE, Uppal GS, Balaggan KS, Tufail A, Munro PM, Milliken AB, Ali RR, Rubin GS, Aylward GW, da Cruz L. Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology. 2007;114(3):561-570. https://doi.org/10.1016/j.ophtha.2006.06.049
  20. Stanga PE, Kychenthal A, Fitzke FW, Halfyard AS, Chan R, Bird AC, Aylward GW. Retinal pigment epithelium translocation and central visual function in age related macular degeneration: preliminary results. Int Ophthalmol. 2001;23(4-6):297-307.
  21. Gouras P, Flood MT, Kjedbye H, Bilek MK, Eggers H. Transplantation of cultured human retinal epithelium to Bruch’s membrane of the owl monkey’s eye. Current Eye Research. 1985;4(3):253-265. https://doi.org/10.3109/02713688509000857
  22. Maximov VV, Lagar’kova MA, Kiselev SL. Gene and cell therapy of retinal diseases. Kletochnaya transplantologiya i tkanevaya inzheneriya. 2012;7(3):12-20. (In Russ.)
  23. Lagar’kova SV, Shilov AG, Gubanova NI, Prokhorovich MA, Kiselev SL. Gistogenez jembrionalnyh stvolovyh kletok cheloveka in vitro v komponenty setchatki glaza. Kletochnye tekhnologii v biologii i meditsine. 2011;4:203-205. (In Russ.)
  24. Kiselev SL, Lagar’kova MA. Stem cells and genetic reprogramming. Vavilovskii zhurnal genetiki i selektsii. 2013;17 (4-2):851-863. (In Russ.)
  25. Bogomazova AN, Vassina EM, Kiselev SL, Lagarkova MA, Lebedeva OS, Nekrasov ED, Panova AV, Philonenko ES, Khomyakova EA, Tskhovrebova LV, Chestkov IV, Shutova MV. Genetic cell reprogramming: A new technology for basic research and applied usage. Russian Journal of Genetics. 2015;51(4):386-396. https://doi.org/10.1134/S102279541504002X.
  26. Miliushina LA, Kuznetsova AV, Aleksandrova MA. Experimental models of human retinal degenerations: induced models. Vestnik oftal’mologii. 2013;129(3):94-97. (In Russ.)
  27. Zhou P, Kannan R, Spee C, Sreekumar PG, Dou G, Hinton DR. Protection of Retina by αB Crystallin in Sodium Iodate Induced Retinal Degeneration. PLoS ONE. 2014;9(5):e98275. https://doi.org/10.1371/journal.pone.0098275
  28. Bartuma H, Petrus-Reurer S, Aronsson M, Westman S, Andr´e H, Kvanta A. In vivo imaging of subretinal bleb-induced outer retinal degeneration in the rabbit. Invest Ophthalmol Vis Sci. 2015;56:2423-2430. https://doi.org/10.1167/iovs.14-16208
  29. Petrus-Reurer S, Bartuma H, Aronsson M, Westman S, Lanner F, André H, Kvanta A. Integration of subretinal suspension transplants of human embryonic stem cell-derived retinal pigment epithelial cells in a large-eyed model of geographic atrophy. Invest Ophthalmol Vis Sci. 2017;58:1314-1322. https://doi.org/10.1167/iovs.16-20738
  30. Bok D, Hall MO. The role of the pigment epithelium in the etiology of inherited retinal dystrophy in the rat. J Cell Biol. 1971;49(3):664-682.
  31. Lund RD, Wang S, Klimanskaya I, Holmes T, Ramos-Kelsey R, Lu B, Girman S, Bischoff N, Sauvé Y, Lanza R. Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells. 2006;8(3):189-199. https://doi.org/10.1089/clo.2006.8.189
  32. Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L, Lanza R, Lund R. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells. 2009;27(9):2126-2135. https://doi.org/10.1002/stem.149
  33. Garg A, Yang J, Lee W, Tsang SH. Stem Cell Therapies in Retinal Disorders. Cells. 2017;6(1):4. https://doi.org/10.3390/cells6010004
  34. Algvere PV, Gouras P, Dafgard Kopp E. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. European Journal of Ophthalmology. 1999;9(3):217-230.
  35. Zhang X, Bok D. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Investigative Ophthalmology and Visual Science. 1998;39(6):1021-1027.
  36. Lebedin MYu, Maiorova KS, Maksimov VV, Bogomazova AN, Lagar’kova MA, Kiselev SL. Somatic cells reprogramming and genome editing for Stargardt disease modeling for investigation and treatment. Geny i Kletki. 2017;12(2):62-70. (In Russ.) https://doi.org/10.23868/201707021
  37. Li Y, Tsai YT, Hsu CW, Erol D, Yang J, Wu WH, Davis RJ, Egli D, Tsang SH. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Molecular Medicine. 2012;18:1312-1319. https://doi.org/10.2119/molmed.2012.00242
  38. Krohne TU, Westenskow PD, Kurihara T, Friedlander DF, Lehmann M, Dorsey AL, Li W, Zhu S, Schultz A, Wang J, Siuzdak G, Ding S, Friedlander M. Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. Stem Cells Translational Medicine. 2012;1(2):96-109. https://doi.org/10.5966/sctm.2011-0057
  39. Westenskow PD, Bucher F, Bravo S, Kurihara T, Feitelberg D, Paris LP, Aguilar E, Lin JH, Friedlander M. iPSC-derived retinal pigment epithelium allografts do not elicit detrimental effects in rats: a follow-up study. Stem Cells Int. 2016;8470263. https://doi.org/10.1155/2016/8470263
  40. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. 2000;18(4):399-404. https://doi.org/10.1038/74447
  41. el Dirini AA, Wang HM, Ogden TE, Ryan SJ. Retinal pigment epithelium implantation in the rabbit: technique and morphology. Graefes Arch Clin Exp Ophthalmol. 1992;230(3):292-300.
  42. Plaza Reyes A, Petrus-Reurer S, Antonsson L, Stenfelt S, Bartuma H, Panula S, Mader T, Douagi I, André H, Hovatta O, Lanner F, Kvanta A. Xeno-Free and Defined Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells Functionally Integrate in a Large-Eyed Preclinical Model. Stem Cell Reports. 2016;6(1):9-17. https://doi.org/10.1016/j.stemcr.2015.11.008
  43. Falkner-Radler CI, Krebs I, Glittenberg C, Povazay B, Drexler W, Graf A, Binder S. Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study. Br J Ophthalmol. 2011;95(3):370-375. https://doi.org/10.1136/bjo.2009.176305
  44. Kamao H, Mandai M, Okamoto S, Sakai N, Suga A, Sugita S, Kiryu J, Takahashi M. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep. 2014;2(2):205-218. https://doi.org/10.1016/j.stemcr.2013.12.007
  45. Stanzel BV, Liu Z, Somboonthanakij S, Wongsawad W, Brinken R, Eter N, Corneo B, Holz FG, Temple S, Stern JH, Blenkinsop TA. Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space. Stem Cell Reports. 2014;2(1):64-77. https://doi.org/10.1016/j.stemcr.2013.11.005
  46. Carr AJ, Smart MJ, Ramsden CM, Powner MB, da Cruz L, Coffey PJ. Development of human embryonic stem cell therapies for age-related macular degeneration. Trends in Neurosciences. 2013;36(7):385-395. https://doi.org/10.1016/j.tins.2013.03.006
  47. Kvanta A, Grudzinska MK. Stem cell-based treatment in geographic atrophy: promises and pitfalls. Acta Ophthalmol. 2014;92(1):21-26. https://doi.org/10.1111/aos.12185
  48. Thumann G, Viethen A, Gaebler A, Walter P, Kaempf S, Johnen S, Salz AK. The in vitro and in vivo behavior of retinal pigment epithelial cells cultured on ultrathin collagen membranes. Biomaterials. 2009;30(3):287-294. https://doi.org/10.1016/j.biomaterials.2008.09.039
  49. Christiansen AT, Tao SL, Smith M, Wnek GE, Prause JU, Young MJ, Klassen H, Kaplan HJ, la Cour M, Kiilgaard JF. Subretinal implantation of electrospun, short nanowire, and smooth poly (e-caprolactone) scaffolds to the subretinal space of porcine eyes. Stem Cells Int. 2012;454295. https://doi.org/10.1155/2012/454295
  50. Hu Y, Liu L, Lu B, Zhu D, Ribeiro R, Diniz B, Thomas PB, Ahuja AK, Hinton DR, Tai YC, Hikita ST, Johnson LV, Clegg DO, Thomas BB, Humayun MS. A novel approach for subretinal implantation of ultrathin substrates containing stem cellderived retinal pigment epithelium monolayer. Ophthalmic Res. 2012;48(4):186-191. https://doi.org/10.1159/000338749
  51. Stanzel BV, Liu Z, Brinken R, Braun N, Holz FG, Eter N. Subretinal delivery of uktrathin rigid-elastic cell carriers using a metallic shooter instrument and biodegradable hydrogel encapsulation. Invest Ophthalmol Vis Sci. 2012;53(1):490-500. https://doi.org/10.1167/iovs.11-8260
  52. Subrizi A, Hiidenmaa H, Ilmarinen T, Nymark S, Dubruel P, Uusitalo H, Yliperttula M, Urtti A, Skottman H. Generation of hESH-derived retinal pigment epithelium on biopolymer coated polyimide membranes. Biomaterials. 2012;33:8047-8054. https://doi.org/10.1016/j.biomaterials.2012.07.033
  53. Aisenbrey S, Zhang M, Bacher D, Yee J, Brunken WJ, Hunter DD. Retinal pigment epithelial cells synthesize laminins, including laminin 5, and adhere to them through alpha3- and alpha6-containing integrins. Invest Ophthalmol Vis Sci. 2006;47(12):5537-5544. https://doi.org/10.1167/iovs.05-1590
  54. Kamao H, Mandai M, Ohashi W, Hirami Y, Kurimoto Y, Kiryu J, Takahashi M. Evaluation of the Surgical Device and Procedure for Extracellular Matrix-Scaffold-Supported Human iPSC-Derived Retinal Pigment Epithelium Cell Sheet Transplantation. Investigative Ophthalmology & Visual Science January. 2017;58(1):211-220. https://doi.org/10.1167/iovs.16-19778
  55. Yang J, Yamato M, Kohno C, Nishimoto A, Sekine H, Fukai F, Okano T. Cell sheet engineering: recreating tissues without biodegradable scaffolds. Biomaterials. 2005;26(33):6415-6422. https://doi.org/10.1016/j.biomaterials.2005.04.061
  56. Kamao H, Mandai M, Okamoto S, Sakai N, Suga A, Sugita S, Kiryu J, Takahashi M. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep. 2014;2(2):205-218. https://doi.org/10.1016/j.stemcr.2013.12.007
  57. Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R. Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet. 2012;379(9817):713-720. https://doi.org/10.1016/S0140-6736(12)60028-2
  58. Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman JP, Davis JL, Heilwell G, Spirn M, Maguire J, Gay R, Bateman J, Ostrick RM, Morris D, Vincent M, Anglade E, Del Priore LV, Lanza R. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2015;385(9967):509-516. https://doi.org/10.1016/S0140-6736(14)61376-3
  59. Schwartz SD, Tan G, Hosseini H, Nagiel A. Subretinal transplantation of embryonic stem cell-derived retinal pig- ment epithelium for the treatment of macular degeneration: An assessment at 4 years. Invest Ophthalmol Vis Sci. 2016;57(5):1-9. https://doi.org/10.1167/iovs.15-18681
  60. Song WK, Park KM, Kim HJ, Lee JH, Choi J, Chong SY, Shim SH, Del Priore LV, Lanza R. Treatment of Macular Degeneration Using Embryonic Stem Cell-Derived Retinal Pigment Epithelium: Preliminary Results in Asian Patients. Stem Cell Reports. 2015;4(5):860-872. https://doi.org/10.1016/j.stemcr.2015.04.005
  61. da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, Vernon A, Daniels JT, Nommiste B, Hasan SM, Gooljar SB, Carr AF, Vugler A, Ramsden CM, Bictash M, Fenster M, Steer J, Harbinson T, Wilbrey A, Tufail A, Feng G, Whitlock M, Robson AG, Holder GE, Sagoo MS, Loudon PT, Whiting P, Coffey PJ. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nature Biotechnology Volume. 2018;36(4):328-337. https://doi.org/10.1038/nbt.4114
  62. Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, Fujihara M, Akimaru H, Sakai N, Shibata Y, Terada M, Nomiya Y, Tanishima S, Nakamura M, Kamao H, Sugita S, Onishi A, Ito T, Fujita K, Kawamata S, Go MJ, Shinohara C, Hata KI, Sawada M, Yamamoto M, Ohta S, Ohara Y, Yoshida K, Kuwahara J, Kitano Y, Amano N, Umekage M, Kitaoka F, Tanaka A, Okada C, Takasu N, Ogawa S, Yamanaka S, Takahashi M. Autologous Induced Stem-Cell — Derived Retinal Cells for Macular Degeneration. The New England Journal of Medicine. 2017;376(11):1038-1046. https://doi.org/10.1056/NEJMoa1608368
  63. https://clinicaltrials.gov/ct2/show/NCT02464956?cond=ipsc+rpe&rank=1
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.